This bill requires health insurance companies and other health carriers in New Jersey to reimburse healthcare providers for vaccines at a rate no lower than the Centers for Disease Control and Prevention (CDC) cost per dose rate listed on the CDC's official price list. It directly affects health insurance carriers (including companies and health plans) and healthcare providers who administer vaccines. The key provision sets a minimum reimbursement rate based on the CDC's actual per-dose cost effective on the date the vaccine was provided. This ensures providers are paid at least the CDC's contracted price, preventing underpayment for vaccine administration.
This bill requires midwives and physicians who provide obstetric care to give pregnant patients written, evidence-based information about all available birthing options (including hospital births, home births, scheduled procedures, and associated health risks) before labor begins. The information must be provided in English and at least seven common non-English languages spoken by limited-English-proficiency patients in New Jersey, based on census data. Providers must also offer annual language-appropriate education on these options during pregnancy. The law applies directly to pregnant patients receiving care from certified midwives or physicians in New Jersey, aiming to improve informed decision-making.
This bill requires New Jersey's Department of Health (DOH) to launch a mobile cancer screening program within 180 days of its effective date. The program will use staffed mobile vehicles deployed across the state's northern, central, and southern regions, each operated by at least one qualified healthcare professional who determines screening methods based on their expertise and available equipment. The bill appropriates $100,000 from the state General Fund to fund this initiative and mandates a report to the Governor and Legislature within two years, summarizing results and suggesting future legislative action. The program directly affects New Jersey residents, particularly those in underserved areas who may gain easier access to cancer screenings.
This bill requires all licensed general and special hospitals in New Jersey to create and implement evidence-based protocols for early sepsis recognition and treatment. The protocols must cover screening, treatment guidelines (with separate adult and pediatric components), infection source identification, antibiotic timing, and exclusion criteria for inappropriate cases. Hospitals must submit protocols to the Department of Health within 120 days of enactment, train staff regularly, and annually report data to track adherence and mortality rates for quality improvement. The law focuses on standardizing care for a life-threatening condition that can cause organ damage or death if untreated.
This bill (S 2980) requires nursing home owners to submit detailed financial and ownership information before transferring ownership or delegating management to third parties. It mandates disclosure of 100% ownership structures, organizational charts, and third-party service providers paying over $200,000 annually, along with resolution of outstanding Medicaid debts. The Department of Health must publicly post applications (with privacy redactions) and allow a 30-day public comment period. These changes aim to increase transparency for prospective buyers and the public while ensuring new owners meet financial and operational standards.
This bill adds 7-hydroxymitragynine (7-OH), a psychoactive compound found in Kratom, to New Jersey's Schedule I list of controlled substances. It directly affects anyone possessing, manufacturing, distributing, or using 7-OH in the state. Under the law, 7-OH would be classified as a substance with "high potential for abuse" and "no accepted medical use," making it illegal for non-medical purposes. Possession of 1 ounce or more would be a second-degree crime, while smaller amounts would be a third-degree crime under New Jersey's drug laws.
S 1796 requires New Jersey health insurance plans to cover prostate cancer screening without cost-sharing (like deductibles or copays) for men aged 40-75 with specific risk factors, including family history of prostate cancer. The bill mandates that group health insurance policies (for groups over 49 people) cover annual screenings - such as digital rectal exams and PSA tests - as well as follow-up tests like imaging or lab work. This applies to all health service, hospital service, and medical service corporation contracts in New Jersey. The law affects insurance carriers by expanding existing coverage requirements and directly benefits men in the specified age group with risk factors.
S 2243 requires every public college and university in New Jersey to create a menstrual equity task force within six months of the law's effective date. The task force, appointed by each institution's president and including diverse campus stakeholders (students, faculty, housing, health centers, etc.), must develop a detailed plan for free menstrual product access within six months. The plan must cover product needs, distribution locations, costs, and a 12-month implementation timeline. Institutions must implement the approved plan within one year, ensuring equal access to menstrual products while reducing stigma. The bill defines "menstrual equity" as removing barriers to care and addressing stigma around menstruation.
This bill requires that parties involved in arbitration cases about personal injury protection (PIP) coverage claims must be represented by a licensed New Jersey attorney. It specifically applies to disputes over PIP coverage, which covers medical costs after car accidents under existing New Jersey law. The requirement takes effect 90 days after the bill becomes law and applies only to new arbitration cases filed after that date. This changes the process for handling certain auto insurance disputes by mandating legal representation in these specific proceedings.
This bill requires health insurance carriers in New Jersey to automatically approve physician applications for provider networks if the physician holds a valid, unrevoked medical license from the state Board of Medical Examiners. It applies to both new applications and renewals, streamlining the process for licensed physicians seeking to join insurance networks. Carriers may request additional non-duplicative information but cannot deny applications based solely on license status. The law affects physicians seeking network participation and insurers managing provider credentialing.
